logo
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Yahoo30-04-2025

FOSTER CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ('Terns' or the 'Company') (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that members of senior management will be participating in a fireside chat at The Citizens Life Sciences Conference on Wednesday, May 7, 2025 at 2:30 p.m. ET.
A live webcast of the fireside chat will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcast will be archived on Terns' website for at least 30 days following the event.
About Terns PharmaceuticalsTerns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns' pipeline contains three clinical stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist, and a preclinical GIPR modulator discovery effort, prioritizing a GIPR antagonist nomination candidate. For more information, please visit: www.ternspharma.com.
Contacts for Terns
InvestorsKaytee Bockinvestors@ternspharma.com
MediaJenna UrbanCG Life media@ternspharma.comSign in to access your portfolio

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Wall Street Review: S&P 500 Breaks 6,000 in Broad Market Rally
Wall Street Review: S&P 500 Breaks 6,000 in Broad Market Rally

Epoch Times

time38 minutes ago

  • Epoch Times

Wall Street Review: S&P 500 Breaks 6,000 in Broad Market Rally

The rally in U.S. stocks continued to broaden this week, driven by a resilient labor market and easing trade tensions between the United States and China. For the first time since it reached an all-time high in February, the S&P 500 Index retook the 6,000 mark on June 6 and closed up 1.5 percent for the week. The Dow Jones Industrial Average gained 1.17 percent to finish at 42,746. The Nasdaq rose by 2.18 percent to 19,529, while the Russell 2000 rallied 3.19 percent.

Trump's Secret AI Strategy Uncovered: Tech Insider Reveals Hidden Role of Elon Musk
Trump's Secret AI Strategy Uncovered: Tech Insider Reveals Hidden Role of Elon Musk

Yahoo

timean hour ago

  • Yahoo

Trump's Secret AI Strategy Uncovered: Tech Insider Reveals Hidden Role of Elon Musk

BALTIMORE, June 07, 2025 (GLOBE NEWSWIRE) -- New briefing claims President Trump has quietly deployed the most advanced artificial intelligence system in U.S. history — and handed the keys to Elon Musk. In a recently surfaced briefing, tech entrepreneur and author James Altucher alleges that Donald Trump's first move back in the Oval Office was more than symbolic — it was tactical. According to Altucher, Trump's repeal of Biden's AI executive order set off a hidden chain reaction that gave Elon Musk the freedom to unleash a classified project known as Project Colossus — an AI facility located in Memphis, Tennessee that may now house the most powerful supercomputer on Earth. 'The Fastest Supercomputer on the Planet' 'It contains not just one or two… but 200,000 units of Nvidia's all-powerful AI chips… making it the most advanced AI facility known to man.' 'The fastest supercomputer on the planet.' — Jensen Huang, Nvidia CEO Altucher says the facility is growing fast — with rumors Musk plans to double its processing power within weeks. A Quiet Reversal. A Bold New Doctrine. 'In one of his FIRST acts as President… Donald Trump overturned Executive Order #14110.' That order — signed by Biden — had imposed regulatory constraints on advanced AI. Altucher claims the reversal was calculated, opening the door for private actors like Musk to move 'without delay or oversight.' Trump later followed with a $500 billion initiative dubbed Stargate, focused on expanding America's AI infrastructure. Beyond Chatbots — Toward Supremacy Altucher argues that what's being built isn't just faster software — it's a new class of intelligence entirely. 'AI 2.0… gives that knowledge to intelligent machines that I believe will solve our problems for us.' He says July 1 could mark a critical turning point, when Musk unveils a 10X expansion to Colossus — potentially redefining U.S. dominance in AI for decades. About James Altucher James Altucher is a computer scientist, bestselling author, and entrepreneur who has worked in AI for over 40 years. He has advised tech firms, built AI trading systems, and contributed to IBM's Deep Blue supercomputer project. His latest research focuses on the convergence of AI, national policy, and private innovation. Media Contact:Derek WarrenPublic Relations ManagerParadigm Press GroupEmail: dwarren@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Is CoreWeave Stock a Buy Now?
Is CoreWeave Stock a Buy Now?

Yahoo

timean hour ago

  • Yahoo

Is CoreWeave Stock a Buy Now?

New AI stock CoreWeave had its initial public offering in March 2025. High demand for AI computing power led to CoreWeave's first-quarter sales soaring more than 400% year over year. The company anticipates sustained revenue growth, but CoreWeave faces financial risks, including operating at a loss. 10 stocks we like better than CoreWeave › Investing in today's stock market can be tricky given the volatile macroeconomic climate, fueled by the Trump administration's ever-shifting tariff policies. But the artificial intelligence sector remains a robust investment opportunity as organizations around the world race to build artificial intelligence (AI) capabilities. Consequently, AI stocks provide the potential for great gains. One example is CoreWeave (NASDAQ: CRWV). The company went public in March at $40 per share. Since then, CoreWeave stock soared to a 52-week high of $166.63 in June. This hot stock remains more than triple its IPO price at the time of this writing. Can it go higher? Evaluating whether now is the time to grab CoreWeave shares requires digging into the company and unpacking its potential as a good investment for the long haul. CoreWeave delivers cloud computing infrastructure to businesses hungry for more computing capacity for their AI systems. The company operates over 30 data centers housing servers and other hardware used by customers to train their AI and develop inference, which is an AI's ability to apply what it learned in training to real-world situations. AI juggernauts such as Microsoft, IBM, and OpenAI, the owner of ChatGPT, are among its roster of customers. The insatiable appetite for AI computing power propelled CoreWeave's business. The company's first-quarter revenue rose a whopping 420% year over year to $981.6 million. Sales growth shows no sign of slowing down. CoreWeave expects Q2 revenue to reach about $1.1 billion. That would represent a strong year-over-year increase of nearly 170% from the prior year's $395 million. The company signs long-term, committed contracts, and as a result, it has visibility into its future revenue potential. At the end of Q1, CoreWeave had amassed a revenue backlog of $25.9 billion, up 63% year over year thanks to a deal with OpenAI. The company forecasts 2025 full-year revenue to come in between $4.9 billion and $5.1 billion, a substantial jump up from 2024's $1.9 billion. Although CoreWeave has enjoyed massive sales success, there are some potential pitfalls with the company. For starters, it isn't profitable. Its Q1 operating expenses totaled $1 billion compared to revenue of $981.6 million, resulting in an operating loss of $27.5 million. Even worse, its costs are accelerating faster than sales, which means the company is moving further away from reaching profitability. CoreWeave's $1 billion in operating expenses represented a 487% increase over the prior year, eclipsing its 420% year-over-year revenue growth. Another area of concern is the company's significant debt load. CoreWeave exited Q1 with $18.8 billion in total liabilities on its balance sheet, and $8.7 billion of that was debt. To keep up with customer demand for computing power, CoreWeave has to spend on expanding and upgrading AI-optimized hardware, and that's not cheap. As it adds customers, the company must expand its data centers to keep pace. Debt is one way it's funding these capital expenditures. Among the risks of buying its stock, CoreWeave admitted, "Our substantial indebtedness could materially adversely affect our financial condition" and that the company "may still incur substantially more indebtedness in the future." In fact, its Q1 debt total of $8.7 billion was a 10% increase from the prior quarter's $7.9 billion in debt. Seeing an increase in both expenses and debt is a concern, but because CoreWeave is a newly public company, there's not much history to know how well it can manage its finances over the long term. Q1 is the only quarter of financial results it's released since its initial public offering. If subsequent quarters reveal a trend toward getting costs and debt under control while continuing to show strong sales growth, CoreWeave stock may prove to be a worthwhile investment over the long run. But for now, only investors with a high risk tolerance should consider buying shares. Even then, another consideration is CoreWeave's stock valuation. This can be assessed by comparing its price-to-sales (P/S) ratio to other AI companies, such as its customer and fellow cloud provider Microsoft and AI leader Nvidia. CoreWeave's share price surged over recent weeks, causing its P/S multiple to skyrocket past that of Nvidia and Microsoft. The valuation suggests CoreWeave stock is overpriced at this time. Although CoreWeave's sales are strong, given its pricey stock and shaky financials, the ideal approach is to put CoreWeave on your watch list. See how it performs over the next few quarters, and wait for its high valuation to drop before considering an investment. Before you buy stock in CoreWeave, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and CoreWeave wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Robert Izquierdo has positions in International Business Machines, Microsoft, and Nvidia. The Motley Fool has positions in and recommends International Business Machines, Microsoft, and Nvidia. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Is CoreWeave Stock a Buy Now? was originally published by The Motley Fool Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store